# Rosuvastatin in Rheumatoid Arthritis (RORA)

> **NCT00679510** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Dundee** · enrollment: 50 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** rosuvastatin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00679510
- **Lead sponsor:** University of Dundee
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00679510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00679510, "Rosuvastatin in Rheumatoid Arthritis (RORA)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00679510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*